CD8A and neoplasm: Unfortunately, the latter is exactly what we would need a predictor to do, to fully understand, for example, what antigenic peptides (if any) drive the CD8+ T cell repertoire selection in human thymi or what (neo)epitopes are recognised by tumour‐infiltrating lymphocytes and could cancer patients be vaccinated against.